Xenon Pharmaceuticals Inc. has successfully completed an underwritten public offering of 12,236,843 common shares at $57.00 per share, raising approximately $707.7 million. The offering included pre-funded warrants for an additional 877,194 shares.

Press Release distribution

National Press Distribution across U.S. Media. Direct Access to Key Decision Making Editors.